https://www.fiercebiotech.com/special-report/nash-four-letters-and-a-multibillion-dollar-opportunityI like how the Heavy weights in the below linked article keep popping up ......Like Gilead or AstraZemeca etc....etc.. Especially now that the ' Front Runner ' selonsertib has been somewhat bumped out of contention.Leaves a lot of room in a ' Multi Billion ' dollar market for other up and coming small Bio's with tremendous I.P and similar potential FAK ' inhibitor ' candidates....... Like Amplia Therapeutics......Attached article above is a very good read about it." Gilead’s ASK1 inhibitor selonsertib had been among the NASH front-runners until this spring, when it failed to improve fibrosis in two phase 3 trials involving more than 1,600 patients. Though selonsertib may be dead in the water as a monotherapy, the company is testing it in combination with its FXR drug cilofexor and its ACC inhibitor firsocostat in a phase 2 study that should yield data by the end of the year. And that’s not all: Gilead is also testing the firsocostat-cilofexor combo with Novo Nordisk’s GLP-1 drug semaglutide. "" AstraZeneca has cotadutide, a dual agonist of GLP-1 and glucagon, and Novartis has licogliflozin, an SGLT1/2 inhibitor. Both posted encouraging data at AASLD, improving enzyme levels and suggesting they might be advanced as treatments for NASH. Finally, Cirius Therapeutics is working on a second-generation thiazolidinedione, or TZD, a class of drugs used to treat diabetes. "
- Forums
- ASX - By Stock
- Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH
https://www.fiercebiotech.com/special-report/nash-four-letters-an...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.38M |
Open | High | Low | Value | Volume |
14.0¢ | 14.0¢ | 13.8¢ | $34.30K | 245.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65549 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 85150 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65549 | 0.135 |
9 | 283481 | 0.130 |
3 | 227518 | 0.125 |
1 | 70001 | 0.120 |
2 | 266206 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 85150 | 2 |
0.145 | 189082 | 4 |
0.150 | 460438 | 10 |
0.155 | 459325 | 4 |
0.160 | 221074 | 5 |
Last trade - 10.57am 20/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |